Mugwort allergy: Study creates basis for vaccine

A research team has discovered key mechanisms of allergy to pollen from the common weed mugwort, thereby also laying the foundation for the development of the world’s first vaccine. Mugwort (Artemisia vulgaris) poses a serious problem for allergic individuals in certain latitudes from July through to September. Currently, the symptoms, which often lead to asthma, can only be treated symptomatically. The recent findings are an essential first step toward causal therapy and prevention of mugwort pollen allergy.
Read Original Article: Mugwort allergy: Study creates basis for vaccine »